Cargando…

Assessing relative COVID-19 mortality: a Swiss population-based study

OBJECTIVE: Severity of the COVID-19 has been previously reported in terms of absolute mortality in SARS-CoV-2 positive cohorts. An assessment of mortality relative to mortality in the general population is presented. DESIGN: Retrospective population-based study. SETTING: Individual information on sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hothorn, Torsten, Bopp, Matthias, Günthard, Huldrych, Keiser, Olivia, Roelens, Maroussia, Weibull, Caroline E, Crowther, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941676/
https://www.ncbi.nlm.nih.gov/pubmed/34006026
http://dx.doi.org/10.1136/bmjopen-2020-042387
_version_ 1783662175338889216
author Hothorn, Torsten
Bopp, Matthias
Günthard, Huldrych
Keiser, Olivia
Roelens, Maroussia
Weibull, Caroline E
Crowther, Michael
author_facet Hothorn, Torsten
Bopp, Matthias
Günthard, Huldrych
Keiser, Olivia
Roelens, Maroussia
Weibull, Caroline E
Crowther, Michael
author_sort Hothorn, Torsten
collection PubMed
description OBJECTIVE: Severity of the COVID-19 has been previously reported in terms of absolute mortality in SARS-CoV-2 positive cohorts. An assessment of mortality relative to mortality in the general population is presented. DESIGN: Retrospective population-based study. SETTING: Individual information on symptomatic confirmed SARS-CoV-2 patients and subsequent deaths from any cause were compared with the all-cause mortality in the Swiss population of 2018. Starting 23 February 2020, mortality in COVID-19 patients was monitored for 80 days and compared with the population mortality observed in the same time of year starting 23 February 2018. PARTICIPANTS: 5 102 300 inhabitants of Switzerland aged 35–95 without COVID-19 (general population in spring 2018) and 20 769 persons tested positively for COVID-19 during the first wave in spring 2020. MEASUREMENTS: Sex-specific and age-specific mortality rates were estimated using Cox proportional hazards models. Absolute probabilities of death were predicted and risk was assessed in terms of relative mortality by taking the ratio between the sex-specific and age-specific absolute mortality in COVID-19 patients and the corresponding mortality in the 2018 general population. RESULTS: Absolute mortalities increased with age and were higher for males compared with females, both in the general population and in positively tested persons. A confirmed SARS-CoV-2 infection substantially increased the probability of death across all patient groups at least eightfold. The highest relative mortality risks were observed among males and younger patients. Male COVID-19 patients exceeded the population hazard for males (HR 1.21, 95% CI 1.02 to 1.44). An additional year of age increased the population hazard in COVID-19 patients only marginally (HR 1.00, 95% CI 1.00 to 1.01). CONCLUSIONS: Healthcare professionals, decision-makers and societies are provided with an additional population-adjusted assessment of COVID-19 mortality risk. In combination with absolute measures of risk, the relative risks presented here help to develop a more comprehensive understanding of the actual impact of COVID-19.
format Online
Article
Text
id pubmed-7941676
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79416762021-03-09 Assessing relative COVID-19 mortality: a Swiss population-based study Hothorn, Torsten Bopp, Matthias Günthard, Huldrych Keiser, Olivia Roelens, Maroussia Weibull, Caroline E Crowther, Michael BMJ Open Epidemiology OBJECTIVE: Severity of the COVID-19 has been previously reported in terms of absolute mortality in SARS-CoV-2 positive cohorts. An assessment of mortality relative to mortality in the general population is presented. DESIGN: Retrospective population-based study. SETTING: Individual information on symptomatic confirmed SARS-CoV-2 patients and subsequent deaths from any cause were compared with the all-cause mortality in the Swiss population of 2018. Starting 23 February 2020, mortality in COVID-19 patients was monitored for 80 days and compared with the population mortality observed in the same time of year starting 23 February 2018. PARTICIPANTS: 5 102 300 inhabitants of Switzerland aged 35–95 without COVID-19 (general population in spring 2018) and 20 769 persons tested positively for COVID-19 during the first wave in spring 2020. MEASUREMENTS: Sex-specific and age-specific mortality rates were estimated using Cox proportional hazards models. Absolute probabilities of death were predicted and risk was assessed in terms of relative mortality by taking the ratio between the sex-specific and age-specific absolute mortality in COVID-19 patients and the corresponding mortality in the 2018 general population. RESULTS: Absolute mortalities increased with age and were higher for males compared with females, both in the general population and in positively tested persons. A confirmed SARS-CoV-2 infection substantially increased the probability of death across all patient groups at least eightfold. The highest relative mortality risks were observed among males and younger patients. Male COVID-19 patients exceeded the population hazard for males (HR 1.21, 95% CI 1.02 to 1.44). An additional year of age increased the population hazard in COVID-19 patients only marginally (HR 1.00, 95% CI 1.00 to 1.01). CONCLUSIONS: Healthcare professionals, decision-makers and societies are provided with an additional population-adjusted assessment of COVID-19 mortality risk. In combination with absolute measures of risk, the relative risks presented here help to develop a more comprehensive understanding of the actual impact of COVID-19. BMJ Publishing Group 2021-03-08 /pmc/articles/PMC7941676/ /pubmed/34006026 http://dx.doi.org/10.1136/bmjopen-2020-042387 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Hothorn, Torsten
Bopp, Matthias
Günthard, Huldrych
Keiser, Olivia
Roelens, Maroussia
Weibull, Caroline E
Crowther, Michael
Assessing relative COVID-19 mortality: a Swiss population-based study
title Assessing relative COVID-19 mortality: a Swiss population-based study
title_full Assessing relative COVID-19 mortality: a Swiss population-based study
title_fullStr Assessing relative COVID-19 mortality: a Swiss population-based study
title_full_unstemmed Assessing relative COVID-19 mortality: a Swiss population-based study
title_short Assessing relative COVID-19 mortality: a Swiss population-based study
title_sort assessing relative covid-19 mortality: a swiss population-based study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941676/
https://www.ncbi.nlm.nih.gov/pubmed/34006026
http://dx.doi.org/10.1136/bmjopen-2020-042387
work_keys_str_mv AT hothorntorsten assessingrelativecovid19mortalityaswisspopulationbasedstudy
AT boppmatthias assessingrelativecovid19mortalityaswisspopulationbasedstudy
AT gunthardhuldrych assessingrelativecovid19mortalityaswisspopulationbasedstudy
AT keiserolivia assessingrelativecovid19mortalityaswisspopulationbasedstudy
AT roelensmaroussia assessingrelativecovid19mortalityaswisspopulationbasedstudy
AT weibullcarolinee assessingrelativecovid19mortalityaswisspopulationbasedstudy
AT crowthermichael assessingrelativecovid19mortalityaswisspopulationbasedstudy